Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1993-10-14
|
pubmed:abstractText |
The role of corticosterone (CCS) in regulating sensitization to amphetamine's locomotor activating effects was measured in female DBA/2 mice that had been sham-operated or adrenalectomized and implanted with CCS-containing or cholesterol pellets. Three days following surgery, the mice were injected with saline and circular open field locomotor activity was measured for a 5-min time period starting 15 min after injection. Over the next 4 days, amphetamine (1.0-10.0 mg/kg) was injected and locomotor response measured. Control animals (sham-operated, cholesterol pellet) showed increased locomotor activity following their first injection of 5.0 mg/kg and 10.0 mg/kg amphetamine, while ADX animals showed increased activity only after treatment with the 10 mg/kg dose. Chronic CCS treatment did not significantly alter initial responsiveness to amphetamine in either sham-operated or ADX animals, but it did alter the dose-dependent sensitization to amphetamine. Both sham-operated and ADX animals implanted with cholesterol pellets showed increased locomotor response to amphetamine (sensitization) following injection with 2.5, 5.0 and 10.0 mg/kg doses of amphetamine. However, the enhancement of locomotor activity was greater in the sham-operated control animals. CCS-treated sham-operated animals exhibited sensitization to the locomotor-activating effects of amphetamine at the lowest dose used (1.0 mg/kg) and increased stereotype following treatment with the higher doses. ADX/CCS animals developed sensitization to the locomotor-activating effects of amphetamine following chronic injection with the 2.5 mg/kg dose, and showed sensitization to amphetamine-induced stereotypy at higher doses.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0006-8993
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
620
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
195-202
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8369955-Adrenalectomy,
pubmed-meshheading:8369955-Amphetamine,
pubmed-meshheading:8369955-Animals,
pubmed-meshheading:8369955-Cholesterol,
pubmed-meshheading:8369955-Corticosterone,
pubmed-meshheading:8369955-Dose-Response Relationship, Drug,
pubmed-meshheading:8369955-Drug Administration Schedule,
pubmed-meshheading:8369955-Drug Implants,
pubmed-meshheading:8369955-Female,
pubmed-meshheading:8369955-Injections, Intraperitoneal,
pubmed-meshheading:8369955-Mice,
pubmed-meshheading:8369955-Mice, Inbred DBA,
pubmed-meshheading:8369955-Motor Activity,
pubmed-meshheading:8369955-Radioimmunoassay,
pubmed-meshheading:8369955-Time Factors
|
pubmed:year |
1993
|
pubmed:articleTitle |
Chronic corticosterone administration enhances behavioral sensitization to amphetamine in mice.
|
pubmed:affiliation |
Institute for Behavioral Genetics, University of Colorado, Boulder 80309.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|